Yale
Yale
New Haven, Connecticut, United States3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention | Asthma in Children | Active, not recruiting | Not applicable | 2026-01-13 | NCT06507943 | |
| Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Active, not recruiting | Not applicable | 2024-12-06 | NCT04301518 | |
| Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2024-03-18 | NCT05280314 |